Sort   by:  
 Page size 
UnknownA Within-Trial Economic Evaluation of a Patient Navigator Program in Children With CKD.
Not available
S-EPMC12446926 | biostudies-literature
UnknownBaseline characteristics of participants in the NAVKIDS2 trial: a patient navigator program in children with chronic kidney disease.
Not available
S-EPMC9584266 | biostudies-literature
UnknownNAVKIDS2 trial: a multi-centre, waitlisted randomised controlled trial of a patient navigator intervention in children with chronic kidney disease - statistical analysis plan and update to the protocol.
Not available
S-EPMC9522454 | biostudies-literature
UnknownThrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.
Not available
S-EPMC6590673 | biostudies-literature
UnknownPrehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial.
Not available
S-EPMC6497986 | biostudies-literature
UnknownAzithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931 | biostudies-literature
UnknownCasirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownAspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213 | biostudies-literature
UnknownConvalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538 | biostudies-literature
Sort   by:  
 Page size